CHRISTINA BAKER: Open Payments
NPI 1619402070 · MASSILLON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$424 in 25 payments from 15 companies in 2025. Trend: 2023 $789 · 2024 $1,435 · 2025 $424
Food & beverage: $424
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 4 | $70 |
| ABBVIE INC. | 3 | $53 |
| Novartis Pharmaceuticals Corporation | 2 | $45 |
| Amgen Inc. | 2 | $34 |
| PFIZER INC. | 2 | $33 |
| Novo Nordisk Inc | 2 | $33 |
| Astellas Pharma US Inc | 2 | $32 |
| Aimmune Therapeutics, Inc. | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Janssen Pharmaceuticals, Inc | 1 | $16 |
Products named: INJECTAFER, LEQVIO, EVENITY, Ozempic, Veozah, LINZESS, ZENPEP, NURTEC ODT.
Industry payments across OH — which companies pay providers there.
